Sekisui Chemical Co., Ltd.

Matsushita Electric Industrial Co., Ltd.

Honda Motor Co., Ltd.

Taro Suzuki

Mitsuhito Teramoto

Akihiko Fujiwara

Jun Inagaki

Ryousuke Suga

Takahiro Nakajima

Takayuki Akamine

Mutsumi Fukuda

Rie Hayashi

Kohei Ohara

Eiken Kuzutani

Kazuya Nishihara

Yukihiko Shirahata

Kunio Yoneto

Provided is a fibrous product that has excellent anti-allergen and antiviral properties, is capable of maintaining excellent outer appearance, and is less likely to cause color migration. Also provided is a processing agent for producing the fibrous product. The fibrous product of the present invention is characterized in having attached to the surface thereof (a) 1.0 to 3.0 g/mof zirconium phosphate, (b) 0.12 to 0.4 g/mof a homopolymer formed of an aromatic sulfonic acid monomer, and (c) 0.2 to 0.8 g/mof a copolymer including a styrene sulfonate salt. In addition, the processing agent of the present invention is characterized in being an aqueous dispersion that contains the components (a), (b), and (c) in a weight ratio of 1.0 to 3.0:0.12 to 0.4:0.2 to 0.8.

Fibrous product and fiber processing agent

The present invention provides an allergen inhibitor which effectively prevents allergens from reacting with specific antibodies, mitigates the allergic symptoms or prevents appearance thereof, and is less likely to cause unpredictable discoloration and discoloration under usual conditions. The allergen inhibitor of the present invention comprises an allergen-inhibiting compound including a linear polymer having at least one of substituents represented by the formulas (1) to (3) at a side chain. Thus, the allergen inhibitor of the present invention shows excellent allergen-inhibiting effects.

Allergen inhibitor, allergen-inhibiting product, allergen inhibiting method, and use as allergen inhibitor

Allergen inhibitor, allergen-inhibiting product, allergen inhibition method, and use as allergen inhibitor

Disclosed herein is an RNA virus infection inhibitor that is capable of effectively inhibiting humans from being infected with RNA viruses to prevent the occurrence of symptoms or, even when symptoms occur, to relieve the symptoms and is less likely to cause unexpected discoloration or discoloration under normal service conditions. The RNA virus infection inhibitor comprises an RNA virus infection-inhibiting compound comprising a linear polymer having, in its side chain, at least one of substituents having structural formulas represented by general formulas (1) to (3).

RNA virus infection inhibitor, method for inhibition of infection by RNA virus, RNA virus infection-inhibiting product, and use as RNA virus infection inhibitor

It is an object of the present invention to provide an allergen suppressor exerting an effect of suppressing an allergen under humidities normally used, and an allergen-suppression processed fiber, which can suppress an allergen adhering to fibers automatically without applying an allergen-suppression process and a method of producing the same. That is, the present invention is an allergen suppressor, which contains a hydrophilic polymer and a component suppressing an allergen.

Allergen suppressor, allergen-suppression processed fiber and method of producing the same

An antiallergen filter of the present invention is characterized in that a water-insoluble high-molecular weight anti-allergenic agent having a phenolic hydroxyl group and a moisture-absorbing material are carried on a filter. Because of using the water-insoluble high-molecular weight substance as an anti-allergenic agent, the antiallergen filter of the present invention is free from a problem that the anti-allergenic agent flows and drops or is detached from the filter due to moisture in the atmosphere, etc. even in a highly humid environment or the like. Further, since the moisture-absorbing material is carried on the filter, moisture that the anti-allergenic agent requires for adsorbing and capturing an allergen and inactivating its allergic activity can be effectively retained on the filter. Thus, the antiallergen filter of the present invention can effectively exert its anti-allergenic effect over a prolonged period of time.

Antiallergen filter, process for producing the same and use thereof

The present invention provides a pharmaceutical preparation for percutaneous absorption comprising a drug-impermeable substrate having provided thereon an adhesive layer comprising a drug and a drug dissolution aid, characterized in that said adhesive is composed of a copolymer essentially consisting of 5 to 35 wt % of N-vinyl-2-pyrrolidone and 65 to 95 wt % of an acrylic acid ester, 3 to 30 wt % of a homopolymer of N-vinyl-2-pyrrolidone is contained in said adhesive layer as the drug dissolution aid, and said drug is a hydrophilic drug having a saturation solubility of 6 to 50 wt % to N-vinyl-2-pyrrolidone. Where the hydrophilic drug is Piroxicam, it is preferred to use a polyoxyethylene alkyl ether and/or a fatty acid alkylolamide as an absorption enhancer in combination.

Pharmaceutical preparation for percutaneous absorption

Growing community of inventors

Osaka, Japan

Taro Suzuki